<DOC>
	<DOCNO>NCT02542501</DOCNO>
	<brief_summary>The intention study investigate many patient prostate cancer , plan treat LHRH analogue without history surgery radiotherapy , suffer LUTS . In addition effect LHRH analogues improvement thesis primary LUTS symptom time investigate .</brief_summary>
	<brief_title>Study Evaluate Presence Lower Urinary Tract Symptoms ( LUTS ) Prostate Cancer Patients Scheduled Receive Luteinizing Hormone Releasing Hormone ( LHRH ) Analogues</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<criteria>Adult men locally advance metastatic prostate cancer schedule receive LHRH analogue . A patient complete IPSS questionnaire last visit , start LHRH analogue , able participate study . This last visit do 6 month baseline visit . Patients provide write informed consent Patients mentally fit completing selfadministered questionnaire Any surgical radiotherapy treatment perform prostate level entry study Patient castrate level testosterone ( &lt; 50 ng/dL ) first IPSS questionnaire Patients also participate clinical study within last 2 month study entry Life expectancy le 12 month</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>